When data and technology expedite growth, how can dealmaking power the value equation? : 2019 EY M&A Firepower report
Publication details: EYGM Limited, 2018Description: 39 p. : gráf., tab.. 1 documento PDFContent type:- texto (visual)
- electrónico
- recurso en línea
Online resources:
Summary: Life sciences M&A in 2018 was strong but failed to meet market expectations as companies focused on portfolio optimization. New digitally savvy entrants are disrupting the larger health ecosystem – and life sciences companies’ business models.
In 2019, life sciences companies must accelerate their dealmaking agendas on two fronts: 1)The creation of focused business models y 2) The acquisition of digital apabilities.
| Cover image | Item type | Current library | Home library | Collection | Shelving location | Call number | Materials specified | Vol info | URL | Copy number | Status | Notes | Date due | Barcode | Item holds | Item hold queue priority | Course reserves | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
CDO | Colección digital | Acceso libre online | 1000020175369 |
Life sciences M&A in 2018 was strong but failed to meet market expectations as companies focused on portfolio optimization. New digitally savvy entrants are disrupting the larger health ecosystem – and life sciences companies’ business models.
In 2019, life sciences companies must accelerate their dealmaking agendas on two fronts: 1)The creation of focused business models y 2) The acquisition of digital apabilities.
There are no comments on this title.
Log in to your account to post a comment.